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1. Introduction 
The bleomycins (BLM) are a group of antibiotics 
isolated as the copper complexes from Streptomyces 
verticillus [1]. They are used in the treatment of 
squamous cell carcinomas. It has been suggested that 
their mode of action involves trand scission of DNA 
[2]. This strand scission is inhibited by metal ions 
such as Cu(II), Zn(II) and Co(II) [3] and a mechanism 
for the scission, involving the Fe(II) complex, has 
been suggested [4,5]. Knowledge of the structures of 
the metal ion complexes of BLM would appear to be 
a prerequisite o an understanding of its function. 
In this study the binding of zinc(II) to BLM was 
investigated using 1H nuclear magnetic resonance 
spectroscopy (NMR). 
2. Experimental 
BLM was a gift from Lundbeck Ltd, Luton, Bed- 
fordshire. It was supplied in ampoules, as for injection 
(copper free and consisting of about 66% BLM A2 
and 33% BLM B2, see fig.l). 
Pulsed Fourier-transform 1HNMR spectra were 
obtained at 270 MHz and 90 MHz on Bruker spectrom- 
eters at temp. 298°K. Quadrature detection was used 
on the 270 MHz spectrometer and 512 transients 
were accumulated. The residual water signal was sup- 
pressed by applying apulse at the appropriate fre- 
quency either prior to application of the measure 
pulse or at all times except during data acquisition 
[6]. Singie-phase detection was used on the 90 MHz 
spectrometer and 1000 transients were accumulated. 
Only the zinc titration was followed at both frequen- 
cies. 2H20 was used as solvent in all experiments and 
provided an internal field-frequency lock. Chemical 
shift values are quoted in parts per million (ppm) 
downfield from sodium 2,2-dimethyl-2-silapentane- 
5-sulphonate (DSS) as internal standard. 
Solutions of BLM (1 mM) were made up in 20 mM 
cacodylate buffer, pH* 6.5 (pH* is a direct meter 
reading uncorrected for the 2H isotope ffect). The 
BLM concentration was checked by comparison of 
peak intensities with the peak intensity given by a 
standard concentration fDSS. Aliquots (10 #1) of a 
solution of spectroscopically pure ZnSO4 • 7 H20 
(10 raM) in 2H20 were added to 0.5 ml samples of the 
BLM solution. The pH* was re-adjusted after each 
addition to about 6.8 using 100 mM solutions of 
NaO2H and/or 2HC1 in 2H20. The pH was measured 
using a Pye-Ingold microelectrode and Radiometer 
pH meter 26. 
3. Results and discussion 
The various bleomycins, as shown in fig.l, differ 
only in their terminal amine residues. All the reso- 
nances in the 1H NMR spectra (fig.2) of bleomycins 
A2 and B2 have recently been assigned [7], except 
for those from the carbohydrate and primary amide 
groups. The most prominent are those due to the 
imidazole C2(H) (A) and imidazole C4(H) (B), the 
pyrimidine methyl protons (C), the bithiazole protons 
(D) and the S-dimethyl protons (E) (the latter from 
BLM A2 only). 
On addition of the zinc(II) solution, at both 
270 MHz and 90 MHz, the C2(H) (7.80 ppm), C4(H) 
Elsevier/North-Holland Biomedical Press 187 
Volume 89, number 2 FEBS LETTERS May 1978 
O NH 2 
[ x NH2 
o 
CH3 H 0 
NH2 T r ~ | ii I i II II 
1"11 H L't'13 ~ ~'n3 
Ho\_ ? ' l l  >.,  
"70 ~ 'O Z ~N/  A R---- NHCH CH CH2S~(~ 
r~ '~~,  o H 2 2 2 \ 
OH ~. . . .~OHo CH, 
~oH 
HO B 2 : R :  NHCH 2CH2CH2CH2NHC~, NH '  
O~"-NH 2 NH 2 
Fig.1. Structure of bleomycins (after [ 1 ]). 
(7.27 ppm) and pyrimidine-Me (2.03 ppm) resonances 
of free BLM decreased in intensity. New resonances 
appeared (at 8.07 ppm, 7.36 ppm and 2.44 ppm), 
increasing in intensity with increasing zinc concentra- 
tion. These are labelled L,M,N, respectively, in fig.2. 
There were other slight changes throughout the 
spectrum, but, significantly, the bithiazole and S- 
dimethyl proton resonances are unaffected inposition 
and intensity by the addition of zinc. The pH* at 
which the experiment was performed iswell above 
the pK a of the imidazole residue (4.7 [8]) and avoids 
the complication of pH shifts of peaks. The changes 
observed are complete at a 1 : 1 mole ratio of Zn :BLM. 
It seems reasonable to assign the new peaks in the 
spectrum of the zinc-BLM complex as follows: 
pyrimidine-Me 2.44 ppm, imidazole C2(H) 8.07 ppm 
and imidazole C4(H) 7.36 ppm, on the assumption 
that the zinc will not affect the chemical shift suffi- 
ciently to invert the positions of the C2(H) imidazole 
and C4(H) imidazole resonances. The pyrimidine-Me 
resonance can be assigned more confidently because 
of its high intensity and good separation from neigh- 
bouring peaks. 
The zinc(II) is therefore in slow exchange [9] at 
both 270 MHz and 90 MHz since the intensity changes 
described above are observed, rather than continuous 
shifts in peak position. The upper limit on the exchange 
rate can be derived since rmAwm>>l for slow 
exchange, where Acom is the chemical shift difference 
of the proton in the bound and free environments, in 
188 
radians, and r m is the lifetime of the bound form [9]. 
This condition refers to individual resonances and if it 
is applied to the resonance with the smallest Aoa m value, 
it will also apply for larger Acom values. The upper 
limit for r m can then be obtained. Thus, for the 
C4(H) resonance, Aoa m is__49.6 radians or 7.9 Hz at 
90 MHz. Therefore rm >>z~-,~.o s and the dissociation 
rate (1/rm) <<49.6 s-1. 
The large effect of zinc on the pyrimidine-Me and 
imidazole resonances suggests that these residues of 
BLM are ligands. Furthermore the imidazole resonances 
in the spectrum of the zinc complex are not sensitive 
to pH* at values greater than 4.7. At pH* values 
below 4.7 the zinc(II) begins to be released from the 
complex and peaks due to free BLM reappear at posi- 
tions depending on the pH* [7]. The zinc is completely 
released by pH* 3.7. The zinc is at all times in slow 
exchange. 
These results are consistent with conclusions reached 
on the basis of chemical evidence [ 10]. The other two 
ligands suggested [10], the a-amino group of the 
terminal diaminopropionic a id residue and the nitro- 
gen of the carbamoyl group, cannot be observed under 
conditions employed in this work due to complete 
exchange of their protons with deuterium from the 
solvent. 
The insensitivity of the resonances associated with 
the S-dimethyl group and the bithiazole moiety to 
zinc(II)-binding suggests that they are not included in 
the first coordination sphere. A model constructed on 
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Fig.2. tH NMR spectra t 270 MHz of BLM with (a) 1 tool, (b) 0.4 tool, (c) 0 tool Zn(lI)/mol BLM. The vertical scale of the aromatic 
region is expanded 4 times in each case. X is a resonance associated with tile buffer. For other labels, see text. 
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the assumption that the imidazole, pyrimidine, a-amino 
group of  the terminal diaminopropiortic a id residue 
and the nitrogen of the carbamoyl group act as ligands 
leaves the bithiazole 'tail' free. It has been suggested 
[ 11 ] that it is the latter which interacts with the 
DNA. The bleomycin may therefore owe its activity 
to this bifunctionality, one part acting as a ligand for 
metal ions, the other interacting with DNA. 
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